Research & development

Rigorous science for new generics

At the heart of our mission: rigorous science combined with a passion for creating and developing generics that meet patients’ needs and improve their quality of life.

Formulation development

A laboratory equipped with state-of-the-art machines to develop formulations.

Analytical development

A cutting-edge laboratory for method development and validation.

Multidisciplinary team

Highly qualified engineers, pharmacists and technicians run both laboratories.

Two missions

Develop, then industrialise

The R&D department develops new generic medicines in various dosage forms and therapeutic areas. It then handles industrial scale-up and the follow-up of marketed products.

  1. 01Active substance selectionChoice of molecule and qualification of active pharmaceutical ingredient (API) suppliers.
  2. 02Pre-formulationPhysicochemical characterisation of the API and excipient compatibility.
  3. 03Formulation & processesFormula development and approval of manufacturing processes.
  4. 04Analytical validationDevelopment and validation of test methods.
  5. 05Stability studiesBatch monitoring under standardised storage conditions.
  6. 06BioequivalenceDemonstration of equivalence with the reference product.
  7. 07Marketing authorisation dossierPreparation and submission of the marketing authorisation dossier.
  8. 08Industrial scale-upScale-up, validation and monitoring of marketed products.

Intellectual property

Five invention patents filed with INNORPI

National Institute for Standardisation and Industrial Property (Tunisia). Click a patent to view the document.